Histophilus somni: A Comprehensive Veterinary Reference on Pathogenesis, Clinical Syndromes, Diagnostics, and Control

Introduction

Histophilus somni (formerly Haemophilus somnus) is a Gram-negative, facultatively anaerobic coccobacillus belonging to the family Pasteurellaceae [1, 2]. It is a major component of the bovine respiratory disease (BRD) complex and is also associated with a wide range of systemic infections in cattle, including thrombotic meningoencephalitis (TME), myocarditis, pericarditis, arthritis, and reproductive disorders [3, 4, 5, 6, 7]. The organism is a commensal of the upper respiratory and urogenital tracts of cattle but can become pathogenic under conditions of stress, viral co-infection, or immunosuppression [4, 6, 8]. This article provides an exhaustive review of H. somni biology, virulence mechanisms, clinical presentations, diagnostic approaches, antimicrobial susceptibility, and control strategies, with dense citation of the peer-reviewed literature.

Taxonomy and Genomic Characteristics

Histophilus somni is classified within the family Pasteurellaceae, order Pasteurellales [1]. The species includes strains previously designated as Haemophilus somnus, Histophilus ovis, and Haemophilus agni, reflecting its host range in cattle and sheep [9]. Whole-genome sequencing has revealed a core genome of approximately 2.2 Mb with a G+C content of about 37% [2, 10, 9]. Complete circular assemblies have been generated for several strains, including strain PDS1537697-81-1 and strain 91 [2, 10]. Comparative genomics has identified integrative and conjugative elements (ICEs) that carry multidrug resistance genes, highlighting the potential for horizontal gene transfer [11]. The genome also encodes a variety of virulence-associated factors, including immunoglobulin-binding proteins, sialic acid uptake systems, and biofilm-associated proteins [12, 13, 14].

Virulence Factors and Pathogenesis

H. somni employs multiple virulence mechanisms to colonize host tissues, evade immune responses, and cause disease. Key virulence factors include:

• Immunoglobulin-binding protein A (IbpA): A Fic domain-containing protein that disrupts host cell signaling and contributes to immune evasion [12]. The DR2 region of IbpA has been used as a species-specific gene target for molecular diagnostics [12].
• Sialic acid uptake system: Encoded by the nanP and nanU genes, this system allows H. somni to scavenge sialic acid from the host environment, which is then incorporated into its lipooligosaccharide (LOS) to mimic host glycans and avoid complement-mediated killing [14].
• Biofilm formation: H. somni forms robust biofilms on 3D bovine respiratory tissue cultures, which may protect the bacteria from antimicrobial agents and host defenses [15]. The biofilm matrix contains proteins and outer membrane vesicles (OMVs) that are enriched under iron-restricted conditions [13].
• Outer membrane proteins (OMPs): The 40 kDa OMP (rOMP40) is immunogenic and has been evaluated as a vaccine antigen [16]. Other OMPs and OMVs are being characterized for their potential as protective antigens [13].
• Hfq and small RNAs: The RNA chaperone Hfq is critical for gene regulation and virulence in H. somni [17]. Hfq-associated small RNAs (sRNAs) have been identified and may regulate stress responses and virulence gene expression [18].
• Extracellular trap formation: H. somni induces the formation of neutrophil extracellular traps (NETs) and macrophage extracellular traps, which may contribute to tissue damage and inflammation [19]. Procoagulant activity of bovine neutrophils is also stimulated by H. somni-conditioned media and extracellular vesicles from infected brain endothelial cells [20].

Clinical Syndromes

H. somni is associated with a spectrum of clinical diseases in cattle, often occurring as part of polymicrobial infections [4, 6]. The major syndromes are summarized in Table 1.

Table 1. Major clinical syndromes associated with Histophilus somni infection in cattle.

Bovine Respiratory Disease

H. somni is a primary bacterial agent in the BRD complex, often acting synergistically with viral pathogens such as BRSV [4, 22, 25]. Experimental co-infection models have demonstrated that dual challenge with BRSV and H. somni results in more severe clinical disease and lung lesions compared to single-pathogen challenge [25]. Metaphylactic administration of macrolides such as tildipirosin or tulathromycin can reduce the severity of H. somni-induced lung lesions when given prior to experimental inoculation [26]. In feedlot cattle, single-dose autogenous vaccines containing H. somni and Pasteurella multocida have been shown to improve performance and profitability [21].

Thrombotic Meningoencephalitis and Cardiac Disease

TME is a characteristic neurological manifestation of H. somni infection, resulting from septic emboli that occlude cerebral vessels [3, 7]. Subacute cardiac death in feedlot cattle has been linked to H. somni-induced myocarditis and pericarditis [3, 7]. Histopathological findings include necrotizing myocarditis, fibrinous pericarditis, and thrombi within cardiac vessels [3].

Reproductive Disorders

H. somni can be transmitted via contaminated semen used for artificial insemination, leading to vaginitis and purulent vaginal discharge [28]. The organism has been detected in raw bovine semen from artificial insemination centers, with a prevalence that warrants screening [27]. Co-infection with bovine herpesvirus 4 significantly extends the service period in dairy cattle with purulent vaginal discharge [8]. Puerperal metritis caused by H. somni has been reported in a Holstein cow, highlighting its role as a unique causative agent of postpartum uterine infection [5].

Diagnosis

Accurate diagnosis of H. somni infection relies on a combination of clinical observation, necropsy findings, and laboratory testing. The diagnostic workflow is illustrated in Figure 1.

flowchart TD
    A[Clinical suspicion: BRD, TME, reproductive signs], > B[Sample collection]
    B, > C[Nasal swab / BAL / lung tissue / vaginal swab / semen]
    C, > D{Primary diagnostic method}
    D, > E[Conventional culture and biochemical identification]
    D, > F[Molecular detection]
    D, > G[Serological assays]
    E, > H[Colony morphology, Gram stain, MALDI-TOF]
    F, > I[PCR / RPA targeting IbpA DR2 or 16S rRNA]
    F, > J[Whole-genome sequencing for genotyping and AMR]
    G, > K[ELISA for antibody detection]
    I, > L[Confirmatory sequencing if needed]
    J, > M[Phylogenetic analysis and resistance gene profiling]
    K, > N[Interpretation of seroprevalence]

Figure 1. Diagnostic workflow for Histophilus somni infection.

Culture and Phenotypic Identification

H. somni is fastidious and requires enriched media (e.g., chocolate agar) supplemented with carbon dioxide [23, 24]. Colonies are small, grayish, and non-hemolytic. Biochemical identification can be performed using commercial systems or matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) [23].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting the IbpA DR2 region or the 16S rRNA gene are widely used for species-specific detection [12]. Recombinase polymerase amplification (RPA) has been developed as a rapid, isothermal alternative to PCR, with high sensitivity and specificity [12]. Whole-genome sequencing (WGS) provides comprehensive genotypic information, including antimicrobial resistance (AMR) determinants and phylogenetic relationships [1, 10, 9, 29]. A nanomaterial optical fiber biosensor assay has also been described for detection of H. somni [30].

Serology

Enzyme-linked immunosorbent assays (ELISAs) using recombinant proteins (e.g., rOMP40, IbpA fragments) can detect antibodies in serum, colostrum, and milk [31, 32, 33, 34, 16]. Precolostral antibody reactivity against conserved H. somni proteins has been studied in stillborn and live calves [31]. Intranasal and subcutaneous administration of recombinant antigens elicits local and systemic humoral immune responses in dairy calves [32]. Hyperimmune serum raised against recombinant proteins can passively transfer antibodies to beef calves [33, 34].

Antimicrobial Resistance

Antimicrobial susceptibility testing of H. somni isolates is critical for guiding therapy. Surveillance studies have documented resistance to several drug classes, including tetracyclines, macrolides, and beta-lactams [35, 23, 24]. A summary of resistance patterns is provided in Table 2.

Table 2. Antimicrobial resistance patterns in Histophilus somni isolates from cattle.

Whole-genome sequencing has revealed that AMR genes are often carried on integrative and conjugative elements (ICEs), facilitating horizontal transfer [11]. Genotype-phenotype concordance for AMR is generally high, supporting the use of WGS for resistance prediction [29].

Vaccination and Immunoprophylaxis

Vaccination against H. somni is an important component of BRD control programs. Both commercial and autogenous vaccines are available [21, 22, 25]. Key vaccine strategies include:

• Subunit vaccines: Recombinant proteins such as rOMP40 and IbpA fragments have been tested in experimental settings [32, 16, 25]. A dual subunit vaccine against BRSV and H. somni protected calves against challenge with both pathogens [25].
• Autogenous vaccines: Single-dose autogenous vaccines containing H. somni and P. multocida improved feedlot cattle performance and reduced mortality in Australian studies [21].
• Hyperimmune serum: Subcutaneous administration of hyperimmune serum against recombinant H. somni proteins increased serum antibody reactivity in beef calves, suggesting potential for passive immunization [33, 34].
• Intranasal vaccination: Intranasal delivery of recombinant antigens induced mucosal IgA responses in dairy calves, which may enhance protection at the respiratory epithelium [32].

Frequently Asked Questions

What is the primary host range of Histophilus somni?

Histophilus somni primarily infects cattle, but it can also cause disease in sheep and other ruminants [9]. Strains isolated from sheep were historically classified as Histophilus ovis or Haemophilus agni [9].

How is Histophilus somni transmitted?

Transmission occurs via direct contact with respiratory secretions, contaminated fomites, or infected semen used for artificial insemination [27, 28]. The bacterium can persist in the upper respiratory tract of carrier animals [24].

What are the most common clinical presentations of Histophilus somni infection?

The most common presentations are bovine respiratory disease (BRD), thrombotic meningoencephalitis (TME), myocarditis, pericarditis, and reproductive disorders such as vaginitis and metritis [3, 4, 5, 7].

Which diagnostic methods are recommended for Histophilus somni?

Culture on enriched media, PCR targeting the IbpA DR2 region, and whole-genome sequencing are recommended [12, 1, 23]. Serological assays can be used for herd-level screening [31, 32].

What antimicrobials are effective against Histophilus somni?

Effective antimicrobials include macrolides (tulathromycin, tildipirosin), tetracyclines, and fluoroquinolones, although resistance has been reported [35, 23, 24, 26]. Susceptibility testing is advised to guide therapy.

Are there effective vaccines for Histophilus somni?

Yes, both commercial and autogenous vaccines are available [21, 22, 25]. Subunit vaccines containing recombinant proteins have shown promise in experimental trials [32, 16, 25].

Can Histophilus somni cause disease in sheep?

Yes, H. somni (formerly Histophilus ovis) can cause polyarthritis, pleuritis, and septicemia in sheep [9].

What is the role of biofilm formation in Histophilus somni pathogenesis?

Biofilm formation enhances bacterial survival on mucosal surfaces and may contribute to chronic infection and antimicrobial tolerance [15, 13].

How does Histophilus somni evade the host immune system?

It employs sialic acid incorporation into LOS to mimic host glycans, produces immunoglobulin-binding proteins, and forms biofilms [12, 13, 14].

Is Histophilus somni associated with reproductive failure in cattle?

Yes, it causes vaginitis, metritis, and abortion, and can be transmitted via contaminated semen [27, 28, 5, 8].

References

[1] Kos D, Ross JA, Allan N, et al. Genome sequences of Pasteurellaceae involved in bovine respiratory disease. Microbiol Resour Announc. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40741748/

[2] Menghwar H, Ma H, Briggs RE, et al. Complete genome sequence of a Histophilus somni strain 91 isolated from a beef calf with pneumonia. Microbiol Resour Announc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39240084/

[3] Van Donkersgoed J, Hill B, Hendrick S, et al. Histophilosis Myocarditis and Pericarditis. Vet Clin North Am Food Anim Pract. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42014285/

[4] Perotta JH, Silva IV, Rodriguez MC, et al. Outbreak of Respiratory Disease Due to Bovine Respiratory Syncytial Virus with Concomitant Infections by Histophilus somni and Pasteurella multocida in Adult Dairy Cows and Calves from Southern Brazil. Animals (Basel). 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41153942/

[5] Molín J, Ainoza A, Armengol R. Histophilus somni as a Unique Causative Agent of Puerperal Metritis (PM) in a Third-Lactation Holstein Cow. Vet Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38535851/

[6] Headley SA, Fritzen JTT, Silva DC, et al. Histophilus somni disease conditions with simultaneous infections by ovine gammaherpesvirus 2 in cattle herds from Southern Brazil. Braz J Microbiol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36759491/

[7] de Yaniz MG, Fiorentino MA, García JP, et al. Clinical-pathological findings induced by Histophilus somni isolated in subacute cardiac death in feedlot cattle. Vet Res Commun. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36342628/

[8] Szenci O, Sassi G, Fodor L, et al. Co-infection with Bovine Herpesvirus 4 and Histophilus somni Significantly Extends the Service Period in Dairy Cattle with Purulent Vaginal Discharge. Reprod Domest Anim. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26690881/

[9] Yatsentyuk S, Pobolelova J, Gordeeva V, et al. Whole-genome sequencing of Histophilus somni strains isolated in Russia. Vet World. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37042002/

[10] Trokhymchuk A, Erickson N, Waldner CL, et al. Complete circular assembly of Histophilus somni PDS1537697-81-1 genome and phenotypic characterization of its antibiotic susceptibility. Microbiol Resour Announc. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38738930/

[11] Farghaly M, Hynes MF, Nazari M, et al. Examination of the horizontal gene transfer dynamics of an integrative and conjugative element encoding multidrug resistance in Histophilus somni. Can J Microbiol. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36495587/

[12] Funk T, Zaheer R, Wobeser B, et al. Evaluating detection of Histophilus somni immunoglobulin-binding protein A DR2 Fic: A species-specific gene target for recombinase polymerase amplification relative to long-read sequencing of respiratory samples from feedlot calves. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42398436/

[13] Lee Y-J, Abdullah M, Chang Y-F, et al. Characterization of proteins present in the biofilm matrix and outer membrane vesicles of Histophilus somni during iron-sufficient and iron-restricted growth: identification of potential protective antigens through in silico analyses. mBio. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40243366/

[14] Menghwar H, Tatum FM, Briggs RE, et al. Characterization of Histophilus somni sialic acid uptake mutant (ΔnanP-ΔnanU) using a mouse septicemia and mortality model. Microb Pathog. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39103126/

[15] Subhadra B, Gandhi N, Cao D, et al. Biofilm formation by Histophilus somni on 3D bovine respiratory tissue cultures. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42350556/

[16] Bajzert J, Szydłowska K, Jawor P, et al. Evaluation of the immunogenic properties of the recombinant Histophilus somni outer membrane protein 40 kDa (rOMP40). BMC Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36401280/

[17] Cao D, Subhadra B, Lee Y-J, et al. Contribution of Hfq to gene regulation and virulence in Histophilus somni. Infect Immun. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38391206/

[18] Subhadra B, Cao D, Jensen R, et al. Identification and initial characterization of Hfq-associated sRNAs in Histophilus somni strain 2336. PLoS One. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37220152/

[19] Hellenbrand KM, Forsythe KM, Rivera-Rivas JJ, et al. Histophilus somni causes extracellular trap formation by bovine neutrophils and macrophages. Microb Pathog. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23022668/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[20] Rivera Rivas JJ, Czuprynski CJ. Procoagulant activity of bovine neutrophils incubated with conditioned media or extracellular vesicles from Histophilus somni stimulated bovine brain endothelial cells. Vet Immunol Immunopathol. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31084894/

[21] Werid GM, Batterham T, O'Meara L, et al. Single-dose Pasteurella multocida and Histophilus somni autogenous vaccines administered at induction significantly improved feedlot cattle performance and profitability in Australia. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40887673/

[22] Berghaus LJ, Corbeil LB, Berghaus RD, et al. Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses. Vaccine. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16777273/

[23] Magstadt DR, Schuler AM, Coetzee JF, et al. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015. J Vet Diagn Invest. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29034785/

[24] Timsit E, Hallewell J, Booker C, et al. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease. Vet Microbiol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28888626/

[25] Gershwin LJ, Behrens NE, McEligot HA, et al. A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge. Vaccine. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28274639/

[26] Confer AW, Snider TA, Taylor JD, et al. Clinical disease and lung lesions in calves experimentally inoculated with Histophilus somni five days after metaphylactic administration of tildipirosin or tulathromycin. Am J Vet Res. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27027834/

[27] Caflisch EA, Pellegrini FV, Georgousi F, et al. Prevalence of Mycoplasmopsis bovis and Histophilus somni in raw bovine semen from artificial insemination collection centers in the United States. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41937057/

[28] Immaru M, Ueno Y, Hinago K, et al. Vaginitis with purulent vaginal discharge caused by artificial insemination using frozen Histophilus somni-contaminated semen. Vet Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38885549/

[29] Owen JR, Noyes N, Young AE, et al. Whole-Genome Sequencing and Concordance Between Antimicrobial Susceptibility Genotypes and Phenotypes of Bacterial Isolates Associated with Bovine Respiratory Disease. G3 (Bethesda). 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28739600/

[30] Bandara AB, Zuo Z, McCutcheon K, et al. Identification of Histophilus somni by a nanomaterial optical fiber biosensor assay. J Vet Diagn Invest. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/30264658/

[31] Baran R, Bajzert J, Stefaniak T, et al. Precolostral antibody reactivity against Histophilus somni conserved proteins and Escherichia coli whole cells in stillborn and live calves. Immunobiology. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39891975/

[32] Bazjert J, Jawor P, Pisarek M, et al. Local and systemic humoral immune responses to Histophilus somni recombinant antigens administered intranasally and subcutaneously to dairy calves. Sci Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39528575/

[33] Bajzert J, Jawor P, Baran R, et al. Correction: Subcutaneous application of hyperimmune serum against Histophilus somni recombinant proteins affects serum antibody reactivity in beef calves. BMC Vet Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38714992/

[34] Bajzert J, Jawor P, Baran R, et al. Subcutaneous application of hyperimmune serum against Histophilus somni recombinant proteins affects serum antibody reactivity in beef calves. BMC Vet Res. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38341558/

[35] Ueno Y, Suzuki K, Takamura Y, et al. Antimicrobial resistance and associated genetic background of Histophilus somni isolated from clinically affected and healthy cattle. Front Vet Sci. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36387383/